West Paces Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10
Closed -$532 503
2019
Q3
$532 Buy
+10
New +$513 ﹤0.01% 477

Other funds holding SYNH

West Paces Advisors's SYNH Position: Q4 2019 in Review

West Paces Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2019, closing a stake of 10 shares — an estimated $532 sold.

West Paces Advisors first reported a position in SYNH in Q3 2019 and held it in 1 quarter. The position peaked at $532 in Q3 2019. 246 funds tracked by Wall St. Rank hold SYNH as of Q4 2019.

  • West Paces Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2019 after selling out during the quarter.
  • West Paces Advisors sold 10 Syneos Health, Inc. Class A Common Stock shares in Q4 2019, an estimated $532.
  • West Paces Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 1 quarter.
  • West Paces Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $532 in Q3 2019.
  • 246 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2019.

Based on West Paces Advisors's 13F filing for Q4 2019, filed 22 Dec 2023.